In 2026, the FDA approved 23 brand-new medications never sold before in the U.S., covering everything from childhood genetic ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

The new roster of the FDA’s advisory panel on drug compounding contains several members who would benefit from the agency endorsing broader use of peptides and other alternative wellness treatments.

The newly installed top U.S. drug regulator has raised concerns about the legality and pace of initiatives to expedite drug decisions, arguing they could threaten Americans’ safety, according to three ...

Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...